|
KMID : 0665220070200040440
|
|
Korean Journal of Food and Nutrition
2007 Volume.20 No. 4 p.440 ~ p.449
|
|
|
Effects of Taurine Supplementation on Serum Lipidperoxide Levels in Middle-aged Women
|
|
Ahn Chang-Soon
|
|
|
Abstract
|
|
|
|
The purpose of this study was to examine the effects of taurine supplementation on serum lipidperoxide(TBARS), a risk factor for cardiovascular disease. The subjects were 22 healthy middle-aged women(33 to 54 years). Serum lipids, thiobarbituric acid reactive substances(TBARS), and plasma taurine levels were measured before and after supplying 3 g of taurine per day for 4 weeks. Plasma taurine was analyzed by Dabsyl-Cl(4-dimethylamino azobenzen-4-sulfonyl-chloride) derivatization and reversed-phase HPLC. Serum TBARS was measured by the Yagi method. Daily dietary taurine intake was calculated by food frequency questionnaire method. The weight and height means of the 22 subjects were 57.9±5.2 kg and 159.2±5.2 cm, respectively. Their percent body fat and waist/hip ratio(WHR) were 26.8% and 0.84, respectively, which were slightly higher than the average for middle-aged Korean women. Serum TC, TG and LDL-C levels tended to decrease after taurine supplementation, but HDL-C was not changed. A positive correlation between plasma taurine and HDL-C was shown after taurine supplementation. The serum TBARS concentration was significantly decreased from 5.05±0.84nmol/㎗ to 4.17±0.64nmol/㎗ after taking taurine(p<0.01), and the plasma taurine concentration was significantly increased from 63.7±14.2nmol/㎗ to 73.8±16.6nmol/㎗ after taurine supplementation(p<0.05). The average dietary intake of taurine was 178.5±50.4 mg/day, which is similar to the average daily taurine intake of Korean women. In conclusion, taurine is an effective nutrient that antagonizes TBARS levels. Therefore, this study suggests that a sufficient taurine intake may be an effective way to prevent cardiovascular disease such as atherosclerosis.
|
|
|
KEYWORD
|
|
|
taurine supplementation, serum lipidperoxide, middle-aged women, cardiovascular disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|